COPD and Lung Diseases

Pulmonary Fibrosis

Pulmonary Fibrosis is a chronic lung disorder considered by the formation of scar tissue in the lungs, which can gradually affect breathing and reduce lung function. The condition may develop due to autoimmune diseases, environmental exposures, certain medications, infections, or unknown causes. Growing research in this field is improving the understanding of disease progression, diagnostic approaches, and treatment options, helping healthcare professionals provide more effective and personalized care. This session will explore key aspects of pulmonary fibrosis, including clinical management, emerging therapies, and ongoing research aimed at improving outcomes for individuals affected by fibrotic lung diseases.

• Idiopathic pulmonary fibrosis (IPF)
• Progressive fibrosing interstitial lung diseases
• Antifibrotic therapies and emerging treatments
• Biomarkers and molecular pathways in pulmonary fibrosis
• Supportive care and lung transplantation